ERIN KRUPSKI: Open Payments
NPI 1306407127 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 91 payments from 17 companies in 2025. Trend: 2023 $2,092 · 2024 $1,919 · 2025 $1,702
Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $429 |
| AstraZeneca Pharmaceuticals LP | 16 | $322 |
| Exact Sciences Corporation | 10 | $139 |
| Lilly USA, LLC | 7 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Amgen Inc. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $63 |
| GlaxoSmithKline, LLC. | 4 | $59 |
Products named: QULIPTA, AIRSUPRA, Cologuard Collection Kit, FARXIGA, MOUNJARO, TRINTELLIX, UBRELVY, JARDIANCE.
Industry payments across NY — which companies pay providers there.
